REBROVICK LINDA - 06 Jul 2026 Form 4 Insider Report for HEALTHSTREAM INC (HSTM)

Reporting relationship: Director
Issuer ticker: HSTM
Reported as of: 06 Jul 2026
Net transaction value: -$174,000
SEC form: 4
Accepted by SEC: 07 Jul 2026, 09:07:59 UTC
Prior SEC filing: 09 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Linda Rebrovick

Key filing fact

REBROVICK LINDA filed Form 4 for HEALTHSTREAM INC (HSTM) on 07 Jul 2026.

Key facts

This page summarizes REBROVICK LINDA's Form 4 filing for HEALTHSTREAM INC (HSTM).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 07 Jul 2026, 09:07.

Change

Previous filing in this sequence was filed on 09 Jun 2026.
Current net transaction value: -$174,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001217283 Primary reporting owner

REBROVICK LINDA

Relationship: Director
Address: 500 11TH AVENUE NORTH, SUITE 850, NASHVILLE
Signature: /s/ Linda Rebrovick
Signature date: 07 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HSTM transaction

Common Stock Holding

Sale

Transaction value: $174,000
Shares: -6,000
Change %: -10%
Price: $29.00
Shares after: 51,329
Date: 06 Jul 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 1 footnote

Footnote F1

The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 21, 2025.